期刊文献+

喹诺酮类药物临床应用及不良反应 被引量:28

Clinical application of quinolone antibiotics and analysis of adverse reactions
原文传递
导出
摘要 目的对喹诺酮类抗菌药物的结构特点、抗菌谱及临床应用范围、不良反应进行分析。方法对医院2010年喹诺酮类抗菌药物临床处方进行统计,分析其药品临床使用处方数、频率和排序及喹诺酮类药物的用途及作用。结果喹诺酮类药物使用频率=药品处方数/药品总处方数,其中使用频率最高的前3位为诺氟沙星、依诺沙星和氧氟沙星,占喹诺酮类抗菌药物处方总量的85.3%,在抗菌药物中运用广泛。结论喹诺酮类在抗菌药物中占有重要地位,应规范、合理应用,防止造成药物不良反应。 OBJECTIVE To analyze the structure feature of quinolone antibacterials, antibacterial spectrum and clinical application and adverse reactions. METHODS The clinical prescriptions on quinolone antibacterial statistics in 2010 were analyzed, including the drug using times, frequency and sorting, as well as the using purpose of quinolone drugs and the effects. RESULTS The quinolone drug using frequency= appearing times of a drug on prescriptions/total number of prescriptions. The top three antibiotics most frequently used were nofloxacin, ciprofloxacin and ofloxacin, which were widely used and accounted for 85.3% of quinolone prescription drugs on prescriptions. CONCLUSION Quinolone drugs are important antibiotics which should be used reasonably and standardly to avoid adverse drug reactions.
作者 戴丽
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第1期163-164,共2页 Chinese Journal of Nosocomiology
关键词 喹诺酮类 临床应用 不良反应 Quinolone Clinical application Adverse reaction
  • 相关文献

参考文献4

二级参考文献25

  • 1李涛,熊自忠,沈继录,周强,徐元宏,王中新.大肠埃希菌与克雷伯菌属细菌qnr基因的检测[J].检验医学,2005,20(2):112-114. 被引量:35
  • 2Drlica K,Malik M.Fluoroquinolones:action and resistance[J].Curr Top Med Chem,2003,3(3):249-282.
  • 3Trans JH,Jacoby GA.Mechanism of plasmid-mediated quinolone resistance[J].Proc Natl Acad Sci USA,2002,99(8):5638-5642.
  • 4Tran JH,Jacoby GA,Hooper DC.The plasmid-mediated protein Qnr protects topoisomerase Ⅳ from ciprofloxacin inhibition and interacts with the ParE subunit[A].Abstr Intersci Conf Antimicrob Agents Chemother,2003.43:abstract No.C1-604.
  • 5Tran JH,Jacoby GA,Hooper DC.Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase[J].Antimicrob Agents Chemother,2005,49(1):118-125.
  • 6Tran JH,Jacoby GA,Hooper DC.Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase Ⅳ[J].Antimicrob Agents Chemother,2005,49(7):3050-3052.
  • 7Jacoby GA,Chow N,Waites KB.Prevalence of plasmid-mediated quinolone resistance[J].Antimicrob Agents Chemother,2003,47(2):559-562.
  • 8Wang M,Sahm DF,Jacoby GA,et al.Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States[J].Antimicrob Agents Chemother,2004,48(4):1295-1299.
  • 9Rodriguez-Martinez JM,Pascual A,Garcia I.Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase[J].J Antimicrob Chemother,2003,52(4):703-706.
  • 10Wang M,Tran JH,Jacoby GA,et al.Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai,China[J].Antimicrob Agents Chemother,2003,47(7):2242-2248.

共引文献193

同被引文献238

引证文献28

二级引证文献179

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部